Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cancer Res ; 49(23): 6600-4, 1989 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-2479467

RESUMO

Taurine (2-aminoethanesulfonic acid) was evaluated as an antimutagen in the Ames Salmonella tester strain assay. Taurine inhibited mutagenesis by doxorubicin (-74%), bleomycin (-55%), mitomycin C (-56%), and 2-aminofluorene (-52%), but not danthrone or benzo(a)pyrene, in strain TA102. In strain TA98, doxorubicin mutagenicity, but not that of 2-aminofluorene or benzo(a)pyrene, was inhibited by taurine. N-Methyl-N'-nitro-N-nitrosoguanidine (-73%), but not dexon, mutagenicity was inhibited by taurine in strain TA100. Taurine inhibited those mutagens against which it was effective in a dose-related fashion. Taurine was more effective in inhibiting doxorubicin mutagenicity in strain TA102 than its analogues hypotaurine, beta-alanine, and guanidinoethanesulfonic acid or alanine or glycine. The observed inhibition may indicate a role for taurine in modulating the activity of oxidant species.


Assuntos
Mutagênicos/antagonistas & inibidores , Taurina/farmacologia , Aminoácidos/farmacologia , Benzenossulfonatos/antagonistas & inibidores , Benzo(a)pireno/antagonistas & inibidores , Bleomicina/antagonistas & inibidores , Relação Dose-Resposta a Droga , Doxorrubicina/antagonistas & inibidores , Fluorenos , Metilnitronitrosoguanidina , Mitomicina , Mitomicinas/antagonistas & inibidores , Testes de Mutagenicidade , Salmonella typhimurium/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA